@FierceMedDev: Study: FDA medical device inspections up 47% under Obama. More | Follow @FierceMedDev
@MarkHFierce: C.R. Bard has settled a DOJ case alleging kickbacks in exchange for use of its prostate cancer treatment. Release | Follow @MarkHFierce
@DamianFierce: Invacare has cleared the first hurdle to getting past an FDA consent decree. Article | Follow @DamianFierce
> St. Jude Medical ($STJ) has enrolled its first patient in the EnligHTN III study, designed to test the safety and effectiveness of the second-generation EnligHTN renal denervation device. More
> U.K. patients have far worse access to insulin pump treatments than in other European nations, a report concludes. Story
> France's Carmat won approval in four countries to start implanting its artificial heart. Article
> Scientists at Tel Aviv University have come up with a biodegradable implant, combined with "regeneration gel," that helped regenerate new nerves in animal tests. Story
> In two studies, ablation outside the pulmonary vein improved treatment of atrial fibrillation. Report
> Diagnostics company Vermillion ($VRML) has raised $13.2 million in a private placement. Item
> Third Rock Ventures, whose portfolio includes diagnostics and device companies, added a Genzyme veteran and former Eli Lilly executive to its team. Release
Biotech News
@FierceBiotech: In case you missed it last week: Henri Termeer rediscovers the 'Genzyme feel' in world of biotech startups. Story | Follow @FierceBiotech
@JohnCFierce: Astellas chops OSI, Perseid ops in global R&D restructuring. Report | Follow @JohnCFierce
@RyanMFierce: AbbVie is forking over $70 million upfront in collab with Alvine for PhII drug against Celiac disease. Release | Follow @RyanMFierce
> Third Rock Ventures expands roster with Alnylam's CEO and Genzyme/Sanofi vet. More
> Suspicious lawmakers query FDA's Hamburg on sudden departure of deputy commish. News
Pharma News
@FiercePharma: Ranbaxy inks record-setting $500M manufacturing settlement with the feds: Report | Follow @FiercePharma
> France slaps Sanofi with $53M fine for 'disparaging' Plavix generics. More
> Merck execs' bogeymen: Animal-rights, disease activists, plus laid-off workers. Story
> AstraZeneca, Astellas among Optimer bidders, Bloomberg sources say. Report
Biotech Research News
@EmilyMFierce: Compound developed by Salk Institute scientists protects against Alzheimer's-related disease behaviors. Report | Follow @EmilyMFierce
> New therapeutic target found for pancreatic cancer. News
> Gene silencing technique could pave way for new class of drugs. Story
> Hormone reverses heart failure symptoms in mice. Item
> Vaccine stops cocaine from reaching brain in monkeys. Article
Pharma Manufacturing News
> FDA says scale of compounding problem is unclear. Report
> Airborne transit mooted as source of remote drug contaminants. Article
> Ranbaxy pleads guilty in $500M case. Story
> USP opens training center in Ghana to raise standards. Item
> WHO clears way for Sanofi's antimalarial ingredient. More